T. Rowe Price Associates’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,047
| Closed | -$196K | – | 2959 |
|
|
2021
Q1 | $196K | Buy |
4,047
+1,250
| +45% | +$60.5K | ﹤0.01% | 2691 |
|
|
2020
Q4 | $275K | Sell |
2,797
-585
| -17% | -$57.5K | ﹤0.01% | 2455 |
|
|
2020
Q3 | $233K | Hold |
3,382
| – | – | ﹤0.01% | 2376 |
|
|
2020
Q2 | $357K | Sell |
3,382
-1,388
| -29% | -$147K | ﹤0.01% | 2188 |
|
|
2020
Q1 | $424K | Buy |
4,770
+121
| +3% | +$10.8K | ﹤0.01% | 2055 |
|
|
2019
Q4 | $531K | Buy |
4,649
+1,524
| +49% | +$174K | ﹤0.01% | 2126 |
|
|
2019
Q3 | $193K | Buy |
3,125
+309
| +11% | +$19.1K | ﹤0.01% | 2379 |
|
|
2019
Q2 | $220K | Buy |
2,816
+5
| +0.2% | +$391 | ﹤0.01% | 2384 |
|
|
2019
Q1 | $379K | Buy |
2,811
+5
| +0.2% | +$674 | ﹤0.01% | 2213 |
|
|
2018
Q4 | $225K | Buy |
2,806
+258
| +10% | +$20.7K | ﹤0.01% | 2370 |
|
|
2018
Q3 | $268K | Sell |
2,548
-739
| -22% | -$77.7K | ﹤0.01% | 2383 |
|
|
2018
Q2 | $329K | Buy |
3,287
+215
| +7% | +$21.5K | ﹤0.01% | 2311 |
|
|
2018
Q1 | $387K | Buy |
3,072
+643
| +26% | +$81K | ﹤0.01% | 2172 |
|
|
2017
Q4 | $406K | Buy |
+2,429
| New | +$406K | ﹤0.01% | 2156 |
|
|
2015
Q4 | – | Sell |
-863
| Closed | -$94K | – | 2550 |
|
|
2015
Q3 | $94K | Buy |
863
+28
| +3% | +$3.05K | ﹤0.01% | 2415 |
|
|
2015
Q2 | $119K | Sell |
835
-61,228
| -99% | -$8.73M | ﹤0.01% | 2431 |
|
|
2015
Q1 | $20.4M | Sell |
62,063
-1,380
| -2% | -$453K | ﹤0.01% | 1126 |
|
|
2014
Q4 | $24.9M | Buy |
+63,443
| New | +$24.9M | 0.01% | 1060 |
|